242 related articles for article (PubMed ID: 19997632)
1. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.
Dutta S; Sullivan JS; Grady KK; Haynes JD; Komisar J; Batchelor AH; Soisson L; Diggs CL; Heppner DG; Lanar DE; Collins WE; Barnwell JW
PLoS One; 2009 Dec; 4(12):e8138. PubMed ID: 19997632
[TBL] [Abstract][Full Text] [Related]
2. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
3. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.
Lyon JA; Angov E; Fay MP; Sullivan JS; Girourd AS; Robinson SJ; Bergmann-Leitner ES; Duncan EH; Darko CA; Collins WE; Long CA; Barnwell JW
PLoS One; 2008 Jul; 3(7):e2830. PubMed ID: 18665258
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults.
Remarque EJ; Roestenberg M; Younis S; Walraven V; van der Werff N; Faber BW; Leroy O; Sauerwein R; Kocken CH; Thomas AW
PLoS One; 2012; 7(6):e38898. PubMed ID: 22768052
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
7. Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide(®) ISA 720 and stabilized with glycine.
Zhu D; McClellan H; Dai W; Gebregeorgis E; Kidwell MA; Aebig J; Rausch KM; Martin LB; Ellis RD; Miller L; Wu Y
Vaccine; 2011 May; 29(20):3640-5. PubMed ID: 21440641
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC
Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111
[TBL] [Abstract][Full Text] [Related]
9. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
Egan AF; Blackman MJ; Kaslow DC
Infect Immun; 2000 Mar; 68(3):1418-27. PubMed ID: 10678955
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.
Kusi KA; Faber BW; Thomas AW; Remarque EJ
PLoS One; 2009 Dec; 4(12):e8110. PubMed ID: 19956619
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
Laurens MB; Kouriba B; Bergmann-Leitner E; Angov E; Coulibaly D; Diarra I; Daou M; Niangaly A; Blackwelder WC; Wu Y; Cohen J; Ballou WR; Vekemans J; Lanar DE; Dutta S; Diggs C; Soisson L; Heppner DG; Doumbo OK; Plowe CV; Thera MA
PLoS One; 2017; 12(3):e0173294. PubMed ID: 28282396
[TBL] [Abstract][Full Text] [Related]
12. posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.
Giersing B; Miura K; Shimp R; Wang J; Zhou H; Orcutt A; Stowers A; Saul A; Miller LH; Long C; Singh S
Infect Immun; 2005 Jul; 73(7):3963-70. PubMed ID: 15972483
[TBL] [Abstract][Full Text] [Related]
13. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
Malar J; 2011 May; 10():108. PubMed ID: 21529376
[TBL] [Abstract][Full Text] [Related]
14. Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits.
Younis S; Faber BW; Kocken CHM; Remarque EJ
BMC Immunol; 2019 Jul; 20(1):25. PubMed ID: 31362695
[TBL] [Abstract][Full Text] [Related]
15. Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.
Miura K; Herrera R; Diouf A; Zhou H; Mu J; Hu Z; MacDonald NJ; Reiter K; Nguyen V; Shimp RL; Singh K; Narum DL; Long CA; Miller LH
Infect Immun; 2013 May; 81(5):1491-501. PubMed ID: 23429537
[TBL] [Abstract][Full Text] [Related]
16. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
Chang SP; Case SE; Gosnell WL; Hashimoto A; Kramer KJ; Tam LQ; Hashiro CQ; Nikaido CM; Gibson HL; Lee-Ng CT; Barr PJ; Yokota BT; Hut GS
Infect Immun; 1996 Jan; 64(1):253-61. PubMed ID: 8557348
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide.
Mullen GE; Giersing BK; Ajose-Popoola O; Davis HL; Kothe C; Zhou H; Aebig J; Dobrescu G; Saul A; Long CA
Vaccine; 2006 Mar; 24(14):2497-505. PubMed ID: 16434128
[TBL] [Abstract][Full Text] [Related]
18. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
Spring MD; Cummings JF; Ockenhouse CF; Dutta S; Reidler R; Angov E; Bergmann-Leitner E; Stewart VA; Bittner S; Juompan L; Kortepeter MG; Nielsen R; Krzych U; Tierney E; Ware LA; Dowler M; Hermsen CC; Sauerwein RW; de Vlas SJ; Ofori-Anyinam O; Lanar DE; Williams JL; Kester KE; Tucker K; Shi M; Malkin E; Long C; Diggs CL; Soisson L; Dubois MC; Ballou WR; Cohen J; Heppner DG
PLoS One; 2009; 4(4):e5254. PubMed ID: 19390585
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.
Stowers AW; Kennedy MC; Keegan BP; Saul A; Long CA; Miller LH
Infect Immun; 2002 Dec; 70(12):6961-7. PubMed ID: 12438375
[TBL] [Abstract][Full Text] [Related]
20. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
Drew DR; Hodder AN; Wilson DW; Foley M; Mueller I; Siba PM; Dent AE; Cowman AF; Beeson JG
PLoS One; 2012; 7(12):e51023. PubMed ID: 23227229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
